FDA Moves Forward On Study Of Drug Ad Offers

Law360, New York (June 27, 2012, 2:48 PM EDT) -- The U.S. Food and Drug Administration said Wednesday it had received the go-ahead to research the effects of promotional offers in direct-to-consumer prescription drug print advertising, a study the agency first proposed nearly two years ago.

The Office of Management and Budget approved the FDA’s request to collect information to conduct the study, according to a notice published in the Federal Register. The agency proposed the study in September 2010, looking to examine what impact, if any, coupons in direct-to-consumer print ads may have on consumers'...
To view the full article, register now.

UK Financial Services

UK Financial Services

Read Our Latest UK Financial Services Coverage

Financial Services Law360 UK provides breaking news and analysis on the financial sector. Coverage includes UK and European Union policy, enforcement, and litigation involving banks, asset management firms, and other financial services organizations.